A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Discovery from space shows that the pyramids were built using water
TikTok to Moderate Content in Kenya After Petition on Morality
Sam’s Club MAP Closes the Loop for Advertisers with Media and Sales Performance Dashboard
MacBook Air 15-inch: Apple reveals big version of its smallest laptop
Penpot Introduces Innovative New Design Collaboration Tools and Partners with Tokens Studio to Build an AI Engine for Design Systems
This low-cost stylus is a $36 alternative to the Apple Pen
Safire Group Awarded Additional U.S. Air Force Small Business Innovation Research (SBIR) Phase II Contract
Heat-Tolerant Africa Coffee Strain Revived in Sierra Leone Pilot